Works by Habermann, Thomas
Results: 197
Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström’s macroglobulinemia.
- Published in:
- Clinical & Experimental Nephrology, 2008, v. 12, n. 4, p. 292, doi. 10.1007/s10157-008-0042-9
- By:
- Publication type:
- Article
DEK regulates B-cell proliferative capacity and is associated with aggressive disease in low-grade B-cell lymphomas.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01145-0
- By:
- Publication type:
- Article
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00942-3
- By:
- Publication type:
- Article
Outcomes of patients with stage I–II Hodgkin lymphoma who had uniform pre-treatment staging with PET/CT and treatment with limited field radiation therapy after chemotherapy.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00711-8
- By:
- Publication type:
- Article
PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
- By:
- Publication type:
- Article
Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
- By:
- Publication type:
- Article
Efficacy of front-line immunochemotherapy for follicular lymphoma: a network meta-analysis of randomized controlled trials.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-021-00598-x
- By:
- Publication type:
- Article
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
- By:
- Publication type:
- Article
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
- By:
- Publication type:
- Article
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00521-4
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00394-z
- By:
- Publication type:
- Article
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
- By:
- Publication type:
- Article
High level MYC amplification in B-cell lymphomas: is it a marker of aggressive disease?
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41408-019-0271-z
- By:
- Publication type:
- Article
Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0233-5
- By:
- Publication type:
- Article
Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-hodgkin lymphoma.
- Published in:
- International Journal of Cancer, 2003, v. 106, n. 5, p. 784, doi. 10.1002/ijc.11311
- By:
- Publication type:
- Article
Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 116, doi. 10.1016/j.clml.2024.07.019
- By:
- Publication type:
- Article
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 8, p. e815, doi. 10.1016/j.clml.2022.04.009
- By:
- Publication type:
- Article
MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S408, doi. 10.1016/S2152-2650(21)01919-4
- By:
- Publication type:
- Article
IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S401, doi. 10.1016/S2152-2650(21)01906-6
- By:
- Publication type:
- Article
Poster: MCL-042: Evolving Frontline Immunochemotherapy for Mantle Cell Lymphoma and the Impact on Survival Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S246, doi. 10.1016/S2152-2650(21)01551-2
- By:
- Publication type:
- Article
Poster: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01536-6
- By:
- Publication type:
- Article
Oral Abstract: IBCL-085: Assessment of Fixed-Duration Therapies for Treatment-Naïve Waldenström Macroglobulinemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01277-5
- By:
- Publication type:
- Article
A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of Metformin Use on the Outcome of Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S270, doi. 10.1016/j.clml.2018.07.192
- By:
- Publication type:
- Article
Clinical Characteristics and Outcome of Transformed Diffuse Large B-Cell Lymphoma in the Rituximab Era: A SEER Database Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S362, doi. 10.1016/j.clml.2017.07.196
- By:
- Publication type:
- Article
Management of Stage IE Primary Gastric Lymphoma.
- Published in:
- Acta Haematologica, 1995, v. 94, n. 2, p. 59, doi. 10.1159/000203975
- By:
- Publication type:
- Article
Impact of lymphoma survivorship clinic visit on patient-centered outcomes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Absolute lymphocyte count predicts overall survival in follicular lymphomas.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 6, p. 596, doi. 10.1111/j.1365-2141.2006.06232.x
- By:
- Publication type:
- Article
Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
- Published in:
- British Journal of Haematology, 1992, v. 80, n. 4, p. 466, doi. 10.1111/j.1365-2141.1992.tb04559.x
- By:
- Publication type:
- Article
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Medical residents' emotional well-being.
- Published in:
- 2002
- By:
- Publication type:
- commentary
Long-Term Follow-Up of Patients with Monoclonal Gammopathy of Undetermined Significance after Kidney Transplantation.
- Published in:
- American Journal of Nephrology, 2012, v. 35, n. 4, p. 365, doi. 10.1159/000337482
- By:
- Publication type:
- Article
Authors' Response.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Relationship Between Increased Personal Well-Being and Enhanced Empathy Among Internal Medicine Residents.
- Published in:
- JGIM: Journal of General Internal Medicine, 2005, v. 20, n. 7, p. 612, doi. 10.1007/s11606-005-0102-8
- By:
- Publication type:
- Article
New developments in the management of diffuse large B-cell lymphoma.
- Published in:
- Hematology, 2012, v. 17, p. 93, doi. 10.1179/102453312X13336169156014
- By:
- Publication type:
- Article
Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study.
- Published in:
- Thyroid, 2016, v. 26, n. 8, p. 1061, doi. 10.1089/thy.2016.0095
- By:
- Publication type:
- Article
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?
- Published in:
- Nutrition & Cancer, 2018, v. 70, n. 7, p. 1088, doi. 10.1080/01635581.2018.1502328
- By:
- Publication type:
- Article
Smoking, alcohol use, obesity, and overall survival from non-Hodgkin lymphoma: a population-based study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 12, p. 2993, doi. 10.1002/cncr.25114
- By:
- Publication type:
- Article
The Treatment of Recurrent/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) With Everolimus Results in Clinical Responses and Mobilization of CLL Cells Into the Circulation.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 9, p. 2201, doi. 10.1002/cncr.25005
- By:
- Publication type:
- Article
A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2826, doi. 10.1002/cncr.22342
- By:
- Publication type:
- Article
Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 4, p. 524, doi. 10.1111/bjh.15720
- By:
- Publication type:
- Article
Event‐free survival at 24 months captures central nervous system relapse of systemic diffuse large B‐cell lymphoma in the immunochemotherapy era.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 149, doi. 10.1111/bjh.14922
- By:
- Publication type:
- Article
Human Pegivirus infection and lymphoma risk and prognosis: a North American study.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 5, p. 644, doi. 10.1111/bjh.15416
- By:
- Publication type:
- Article
A susceptibility locus for classical Hodgkin lymphoma at 8q24 near <italic>MYC</italic>/<italic>PVT1</italic> predicts patient outcome in two independent cohorts.
- Published in:
- 2018
- By:
- Publication type:
- Abstract
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
- By:
- Publication type:
- Article
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 50, doi. 10.1111/bjh.14813
- By:
- Publication type:
- Article
Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 3, p. 427, doi. 10.1111/bjh.14688
- By:
- Publication type:
- Article
Rituximab extended schedule or retreatment trial for low tumour burden non-follicular indolent B-cell non-Hodgkin lymphomas: Eastern Cooperative Oncology Group Protocol E4402.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 6, p. 867, doi. 10.1111/bjh.14007
- By:
- Publication type:
- Article
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 4, p. 530, doi. 10.1111/bjh.13634
- By:
- Publication type:
- Article